Inhibition of the effect of high glucose on the expression of Smad in human peritoneal mesothelial cells

International Journal of Artificial Organs

Volumn 27, Issue 10, 2004, Pages 828-834

  Yao, Q ^a,b   Qian, J Q ^b   Lin, X H ^b   Lindholm, Bengt ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiotensin II receptor blocker; High glucose; Peritoneal fibrosis; Smads; TGF 1

Indexed keywords

GENE EXPRESSION; GLUCOSE; PROTEINS;

ANGIOTENSIN II; ANGIOTENSIN II RECEPTOR BLOCKER; GENE LEVELS; HIGH GLUCOSE; LOSARTAN; MESOTHELIAL CELLS; PERITONEAL DIALYSIS; PERITONEAL FIBROSE; SMADS; TGF-Β1;

POLYOLS;

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; GLUCOSE; LOSARTAN; LOSARTAN POTASSIUM; MANNITOL; PERITONEAL DIALYSIS FLUID; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; ANGIOTENSIN RECEPTOR ANTAGONIST; DIALYSIS FLUID; DNA BINDING PROTEIN; MESSENGER RNA; SMAD2 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DRUG MECHANISM; FIBROSIS; HUMAN; HUMAN CELL; MESOTHELIUM CELL; OSMOLALITY; PERITONEAL CAVITY; PERITONEAL DIALYSIS; SIGNAL TRANSDUCTION; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; METABOLISM; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOTTING, WESTERN; CELLS, CULTURED; DIALYSIS SOLUTIONS; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; GENES, TUMOR SUPPRESSOR; GLUCOSE; HUMANS; LOSARTAN; MANNITOL; PERITONEAL CAVITY; PERITONEAL DIALYSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 16644387378     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880402701003     Document Type: Article

References (29)

1. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI. What really happens to people on long-term peritoneal dialysis? Kidney Int 1998; 54: 2207-17.
2. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-9.
3. Border WA, Noble NA. TGF-beta in kidney fibrosis: A target for gene therapy. Kidney Int 1997; 51: 1388-96.
4. Reisdorf P, Lawrence DA, Sivan V, Klising E, Martin MT. Alteration of transforming growth factor-beta1 response involves down-regulation of Smad3 signaling in myofibroblasts from skin fibrosis. Am J Pathol 2001; 159: 263-72.
5. Schuppan D, Porov Y. Hepatic fibrosis: From bench to bedside. J Gastroenterol Hepatol 2002; 17 (suppl 3): S300-5.
6. Ha H, Yu MR, Lee HB. High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 2001; 59: 463-70.
7. Ha H, Cha MK, Choi HN, Lee HB. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int 2002; 22: 171-7.
8. Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997; 390: 465-71.
9. Hung KY, Huang JW, Chen CT, Lee PH, Tsai TJ. Pentoxifylline modulates intracellular signalling of TGF-beta in cultured human peritoneal mesothelial cells: Implications for prevention of encapsulating peritoneal sclerosis. Nephrol Dial Transplant 2003; 18: 670-6.
10. Mezzano SA, Ruiz-Ortega M, Egido J. Angiotensin II and renal fibrosis. Hypertension 2001; 38: 635-8.
11. Duman S, Gunal AI, Sen S, Asci G, Ozkahya M, Terzioglu E, et al. Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution? Perit Dial Int 2001; 21: 219-24.
12. Noh H, Kim J, Yu M, Ha H, Lee H. Renin angiotensin system in human peritoneal mesothelial cells (Abstract). J Am Soc Nephrol 2003; 14: 218A.
13. Yung S, Thomas GJ, Stylianou E, Williams JD, Coles GA, Davies M. Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans. Am J Pathol 1995; 146: 520-9.
14. Kjellman C, Olofsson SP, Hansson O, Von Schantz T, Lindvall M, Nilsson I, et al. Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma. Int J Cancer 2000; 89: 251-8.
15. Rocco MV, Chen Y, Goldfarb S, Ziyadeh FN. Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule. Kidney Int 1992; 41: 107-14.
16. Hoffman BB, Sharma K, Zhu Y, Ziyadeh FN. Transcriptional activation of transforming growth factor-beta1 in mesangial cell culture by high glucose concentration. Kidney Int 1998; 54: 1107-16.
17. Han DC, Isono M, Hoffman BB, Ziyadeh FN. High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGF-beta. J Am Soc Nephrol 1999; 10: 1891-9.
18. Li JH, Huang XR, Zhu HJ, Johnson R, Lan HY. Role of TGF-beta signaling in extracellular matrix production under high glucose conditions. Kidney Int 2003; 63: 2010-9.
19. Isono M, Chen S, Hong SW, Iglesias-de la Cruz MC, Ziyadeh FN. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells. Biochem Biophys Res Commun 2002; 102; 296: 1356-65.
20. Zimmerman CM, Padgett RW. Transforming growth factor beta signaling mediators and modulators. Gene 2000; 249: 17-30.
21. Roberts AB, Piek E, Bottinger EP, Ashcroft G, Mitchell JB, Flanders KC. Is Smad3 a major player in signal transduction pathways leading to fibrogenesis? Chest 2001; 120 (suppl 1): S43-7.
22. Jonk LJ, Itoh S, Heldin CH, ten Dijke P, Kruijer W. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 1998; 273: 21145-52.
23. Piek E, Ju WJ, Heyer J, Escalante-Alcalde D, Stewart CL, Weinstein M, et al. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem 2001; 276: 19945-53.
24. Singh R, Alavi N, Singh AK, Leehey DJ. Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation. Diabetes 1999; 48: 2066-73.
25. Wong TY, Phillips AO, Witowski J, Topley N. Glucose-mediated induction of TGF-beta 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int 2003; 63: 1404-16.
26. Naiki Y, Maeda Y, Matsuo K, Yonekawa S, Sakaguchi M, Iwamoto I, et al. Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis. J Nephrol 2003; 16: 95-102.
27. Osei SY, Price DA, Laffel LM, Lansang MC, Hollenberg NK. Effect of angiotensin II antagonist eprosartan on hyperglycemia-induced activation of intrarenal renin-angiotensin system in healthy humans. Hypertension 2000; 36: 122-6.
28. Weigert C, Brodbeck K, Klopfer K, Haring HU, Schleicher ED. Angiotensin II induces human TGF-beta 1 promoter activation: Similarity to hyperglycaemia. Diabetologia 2002; 45: 890-8.
29. Weigert C, Sauer U, Brodbeck K, Pfeiffer A, Haering H-U, Schleicher ED. AP-1 proteins mediate hyperglycemia induced activation of the human TGF-beta1 promoter in mesangial cells. J Am Soc Nephrol 2000; 11: 2007-16.